Inventor · disambiguated record
Neil Aronin
Also filed as: ARONIN NEIL
26 granted patents·20 pending applications·207 citations·filing 1997–2024
96Inventor score
Top patents by PatentIndex Score
46 records- 0198US11230713B2Oligonucleotide compounds for targeting huntingtin mRNAUNIV MASSACHUSETTS·Filed 2020·Granted Jan 25, 2022·13 cites·30 claims
- 0297US10774327B2Oligonucleotide compounds for targeting huntingtin mRNAUNIV MASSACHUSETTS·Filed 2019·Granted Sep 15, 2020·14 cites·20 claims
- 0397US9809817B2Oligonucleotide compounds for targeting huntingtin mRNAUNIV MASSACHUSETTS·Filed 2016·Granted Nov 7, 2017·33 cites·41 claims
- 0495US10435688B2Oligonucleotide compounds for targeting huntingtin mRNAUNIV MASSACHUSETTS·Filed 2017·Granted Oct 8, 2019·15 cites·24 claims
- 0593US12173286B2Fully stabilized asymmetric siRNAUNIV MASSACHUSETTS·Filed 2020·Granted Dec 24, 2024·2 cites·39 claims
- 0693US10633653B2Bioactive conjugates for oligonucleotide deliveryUNIV MASSACHUSETTS·Filed 2016·Granted Apr 28, 2020·14 cites·18 claims
- 0793US8987222B2Single nucleotide polymorphism (SNP) targeting therapies for the treatment of huntington'S diseaseARONIN NEIL·Filed 2010·Granted Mar 24, 2015·24 cites·21 claims
- 0893US8680063B2RNA interference for the treatment of gain-of-function disordersARONIN NEIL·Filed 2010·Granted Mar 25, 2014·27 cites·17 claims
- 0992US11827882B2Modified oligonucleotides targeting SNPsUNIV MASSACHUSETTS·Filed 2019·Granted Nov 28, 2023·7 cites·20 claims
- 1091US10457940B2AAV treatment of Huntington's diseaseUNIV MASSACHUSETTS·Filed 2017·Granted Oct 29, 2019·5 cites·22 claims
- 1191US7947658B2RNA interference for the treatment of gain-of-function disordersUNIV MASSACHUSETTS·Filed 2004·Granted May 24, 2011·28 cites·9 claims
- 1289US11753638B2Conjugated oligonucleotidesUNIV MASSACHUSETTS·Filed 2017·Granted Sep 12, 2023·7 cites·18 claims
- 1388US11773392B2AAV treatment of Huntington's diseaseUNIV MASSACHUSETTS·Filed 2021·Granted Oct 3, 2023·1 cites·20 claims
- 1487US10945955B2Artificial exosome composition and related methodsUNIV MASSACHUSETTS·Filed 2019·Granted Mar 16, 2021·2 cites·20 claims
- 1587US10513710B2Exosomal loading using hydrophobically modified oligonucleotidesUNIV MASSACHUSETTS·Filed 2015·Granted Dec 24, 2019·5 cites·42 claims
- 1687US2025188458A1Fully stabilized asymmetric sirnaUNIV MASSACHUSETTS·Filed 2024·Application pending·0 cites
- 1786US11046957B2AAV treatment of Huntington's diseaseUNIV MASSACHUSETTS·Filed 2019·Granted Jun 29, 2021·2 cites·16 claims
- 1884US11505807B2Exosomal loading using hydrophobically modified oligonucleotidesUNIV MASSACHUSETTS·Filed 2019·Granted Nov 22, 2022·2 cites·18 claims
- 1984US11299734B2RNA interference for the treatment of gain-of-function disordersUNIV MASSACHUSETTS·Filed 2019·Granted Apr 12, 2022·1 cites·9 claims
- 2083US12024706B2Modified oligonucleotides targeting SNPsUNIV MASSACHUSETTS·Filed 2020·Granted Jul 2, 2024·1 cites·20 claims
- 2180US2025059533A1Bioactive conjugates for oligonucleotide deliveryUNIV MASSACHUSETTS·Filed 2024·Application pending·0 cites
- 2278US9434943B2RNA interference for the treatment of gain-of-function disordersUNIV MASSACHUSETTS·Filed 2014·Granted Sep 6, 2016·2 cites·12 claims
- 2378US2022251554A1Oligonucleotide compounds for targeting huntingtin mrnaUNIV MASSACHUSETTS·Filed 2021·Application pending·0 cites
- 2476US10344277B2RNA interference for the treatment of gain-of-function disordersUNIV MASSACHUSETTS·Filed 2016·Granted Jul 9, 2019·1 cites·6 claims
- 2576US2024327836A1MODIFIED OLIGONUCLEOTIDES TARGETING SNPsUNIV MASSACHUSETTS·Filed 2024·Application pending·0 cites
- 2675US9914924B2Methods and compositions for treating neurological diseaseUNIV MASSACHUSETTS·Filed 2015·Granted Mar 13, 2018·1 cites·20 claims
- 2771US2024132888A1MODIFIED OLIGONUCLEOTIDES TARGETING SNPsUNIV MASSACHUSETTS·Filed 2023·Application pending·0 cites
- 2870US12023407B2Artificial exosome composition and related methodsUNIV MASSACHUSETTS·Filed 2021·Granted Jul 2, 2024·0 cites·20 claims
- 2970US2024084297A1Conjugated oligonucleotidesUNIV MASSACHUSETTS·Filed 2023·Application pending·0 cites
- 3066US12077755B2Bioactive conjugates for oligonucleotide deliveryUNIV MASSACHUSETTS·Filed 2020·Granted Sep 3, 2024·0 cites·11 claims
- 3162US2010151470A1Methods and compositions for locating snp heterozygosity for allele specific diagnosis and therapyUNIV MASSACHUSETTS·Filed 2009·Application pending·0 cites
- 3262US2007105803A1Methods and compositions for treating neurological diseaseMANOHARAN MUTHIAH·Filed 2006·Application pending·0 cites
- 3362US2013261166A1Methods and compositions for treating neurological diseaseMANOHARAN MUTHIAH·Filed 2013·Application pending·0 cites
- 3462US2007161591A1Methods and compositions for treating neurological diseaseUNIV MASSACHUSETTS·Filed 2006·Application pending·0 cites
- 3558US2023089312A1Inducible single aav system and uses thereofUNIV MASSACHUSETTS·Filed 2021·Application pending·0 cites
- 3658US2017369882A1Fully stabilized asymmetric sirnaUNIV MASSACHUSETTS·Filed 2017·Application pending·0 cites
- 3758US2012214861A1Methods and compositions for treating neurological diseaseARONIN NEIL·Filed 2011·Application pending·0 cites
- 3857US2011251257A1Methods and compositions for treating neurological diseaseMANOHARAN MUTHIAH·Filed 2010·Application pending·0 cites
- 3957US2010267810A1Methods and compositions for treating neurological diseaseUNIV MASSACHUSETTS·Filed 2010·Application pending·0 cites
- 4056US2011027882A1Methods and Compositions for Treating Neurological DiseaseMANOHARAN MUTHIAH·Filed 2010·Application pending·0 cites
- 4154US2009186410A1Rna silencing compositions and methods for the treatment of huntington's diseaseUNIV MASSACHUSETTS·Filed 2009·Application pending·0 cites
- 4254US2016319278A1Fully stabilized asymmetric sirnaUNIV MASSACHUSETTS·Filed 2016·Application pending·0 cites
- 4350US12268755B2Allele-specific inactivation of mutant HTT via gene editing at coding region single nucleotide polymorphismsUNIV MASSACHUSETTS·Filed 2022·Granted Apr 8, 2025·0 cites·11 claims
- 4446US2007259827A1Compositions and methods for enhancing discriminatory RNA interferenceUNIV MASSACHUSETTS·Filed 2007·Application pending·0 cites
- 4538US2005256072A1Dual functional oligonucleotides for use in repressing mutant gene expressionUNIV MASSACHUSETTS·Filed 2005·Application pending·0 cites
- 4617US6602673B2Huntingtin-related therapeutics and bioassayUNIV MASSACHUSETTS·Filed 1997·Granted Aug 5, 2003·0 cites·7 claims
Join the waitlist — get patent alerts
Get an alert when Neil Aronin files or is granted a new patent.
We store only your email — no account needed. See our privacy policy.
Identity basis: PatentsView inventor disambiguation (2025Q4-odp release). How scoring works →